How Much Bacteriostatic Water for SS-31? (Chart)

Overview of Reconstitution Volume Selection for SS-31

Reconstituting the synthetic tetrapeptide SS-31 (also known as Elamipretide or D-Arg-Dmt-Lys-Phe-NH2) requires precise volumetric planning to ensure exact concentration for downstream experimental applications. Because SS-31 is supplied as a lyophilized powder, adding a sterile diluent like 0.9% benzyl alcohol-preserved bacteriostatic water restores the peptide into a homogeneous liquid solution suitable for laboratory pipetting.

The volume of bacteriostatic water added does not alter the total mass of active peptide present in the vial; rather, it dictates the final concentration (measured in milligrams per milliliter, or mg/mL). Selecting the optimal volume depends on the specific requirements of the assay, microfluidic setup, or injection volume calculated for rodent models. Researchers should review our complete catalog of research peptides to verify vial sizes and analytical specifications before initiating preparation.

When planning experimental protocols, researchers can also utilize the interactive reconstitution calculator to instantly compute exact liquid volumes, concentration outputs, and volumetric draw requirements across varying vial masses.

The Arithmetic Behind SS-31 Dilution Calculations

Calculating the resulting concentration of an SS-31 solution involves a straightforward quotient: target concentration equals the total peptide mass in milligrams divided by the total volume of diluent added in milliliters (C = m / V). For instance, if a researcher adds 2.0 mL of bacteriostatic water to a 10 mg vial of SS-31 research peptide, the calculation yields: 10 mg ÷ 2.0 mL = 5.0 mg/mL.

To determine the volume of solution required to yield a specific target dose in milligrams, researchers invert the formula: required volume (mL) = desired mass (mg) ÷ concentration (mg/mL). If a preclinical assay protocol calls for a 0.5 mg dose of SS-31 from a 5.0 mg/mL reconstituted stock, the required volume is 0.5 mg ÷ 5.0 mg/mL = 0.1 mL (or 100 microliters).

Maintaining rigorous volumetric precision requires using calibrated single-channel or multi-channel micropipettes rather than standard disposable syringes when measuring diluents in analytical settings. Accounting for displacement volume is generally unnecessary for low-mass peptide vials (e.g., 10 mg or 50 mg), as the solid mass contributes negligible displacement once fully dissolved in liquid diluent.

SS-31 Reconstitution Chart for 10 mg Research Vials

For standard 10 mg lyophilized vials of SS-31, varying the volume of bacteriostatic water between 1.0 mL and 5.0 mL yields concentrations spanning high-density stock solutions down to diluted working preparations. The chart below delineates the resulting concentration and volumetric metrics for common reconstitution volumes:

1.0 mL Diluent Addition: Yields a concentration of 10.0 mg/mL (10,000 mcg/mL). Every 0.1 mL (100 µL) contains exactly 1.0 mg of SS-31. This high concentration is ideal for creating concentrated stock solutions intended for subsequent serial dilution.

2.0 mL Diluent Addition: Yields a concentration of 5.0 mg/mL (5,000 mcg/mL). Every 0.1 mL (100 µL) contains 0.5 mg of SS-31. This standard ratio balances ease of volumetric measurement with liquid volume management in laboratory settings.

3.0 mL Diluent Addition: Yields a concentration of 3.33 mg/mL (3,333 mcg/mL). Every 0.1 mL (100 µL) contains approximately 0.33 mg of SS-31. This concentration is frequently selected when low-margin pipetting error is desired across repeated liquid transfers.

5.0 mL Diluent Addition: Yields a concentration of 2.0 mg/mL (2,000 mcg/mL). Every 0.1 mL (100 µL) contains 0.2 mg of SS-31. Dilute solutions of this nature are well-suited for direct administration in animal models where larger volumetric margins prevent micro-dosing variances.

SS-31 Reconstitution Chart for 50 mg Bulk Research Vials

When handling larger 50 mg lyophilized vials of SS-31 intended for high-throughput in vitro testing or long-term preclinical studies, diluent volumes must be scaled accordingly to maintain manageable working concentrations:

1.0 mL Diluent Addition: Yields a highly concentrated stock of 50.0 mg/mL (50,000 mcg/mL). A 0.1 mL aliquot delivers 5.0 mg of active peptide. This option requires precise micropipetting due to high solute density.

2.0 mL Diluent Addition: Yields a concentration of 25.0 mg/mL (25,000 mcg/mL). A 0.1 mL aliquot delivers 2.5 mg of SS-31. This concentration is typically reserved for master stock preparation prior to aliquoting.

3.0 mL Diluent Addition: Yields a concentration of 16.67 mg/mL (16,670 mcg/mL). A 0.1 mL aliquot delivers 1.67 mg of SS-31, providing a mid-tier concentration for automated liquid handling systems.

5.0 mL Diluent Addition: Yields a concentration of 10.0 mg/mL (10,000 mcg/mL). A 0.1 mL aliquot delivers 1.0 mg of SS-31. This configuration matches the concentration of a 10 mg vial reconstituted with 1.0 mL, establishing uniform dosing across different vial sizes.

Step-by-Step Laboratory Reconstitution Protocol

To preserve the structural integrity of the SS-31 peptide and ensure sterility, laboratory personnel should adhere to a standardized aseptic reconstitution procedure. Begin by wiping the rubber stopper of the SS-31 vial and the bacteriostatic water diluent vial with 70% isopropyl alcohol swabs inside a certified laminar flow hood.

Using a sterile pipette or syringe, draw the exact pre-calculated volume of bacteriostatic water (e.g., 2.0 mL). Insert the needle through the center of the rubber septum at a slight angle. Allow the vacuum inside the vial to pull the diluent in naturally; if no vacuum is present, depress the plunger slowly, directing the liquid stream against the glass wall of the vial rather than directly onto the lyophilized powder cake.

Once the diluent is introduced, gently swirl the vial in a circular motion until the lyophilized powder is completely dissolved into a clear, colorless liquid. Never shake or vortex the vial vigorously, as violent agitation can induce mechanical shear stress, leading to peptide denaturation or aggregation. Verify full dissolution under bright laboratory light prior to drawing sample aliquots.

Aliquoting, Solubility, and Storage Stability Protocols

SS-31 exhibits high solubility in aqueous buffers and bacteriostatic water due to its cationic tetrapeptide structure. However, once reconstituted, peptides are subject to hydrolytic degradation and oxidation over extended periods. To maintain chemical stability, reconstituted SS-31 stored with bacteriostatic water (0.9% benzyl alcohol) should be refrigerated at 2°C to 8°C and utilized within 28 days.

For long-term experimental timelines, researchers should aliquot the freshly reconstituted stock into sterile, polypropylene microcentrifuge tubes to prevent repeated freeze-thaw cycles. Freeze-thaw cycles cause cryogenic stress that can compromise peptide bond stability. Aliquots designated for long-term storage should be frozen immediately at -20°C or -80°C.

Before conducting analytical assays, verify lot purity and chemical identity by referencing our lot-specific Certificates of Analysis (COA). PX1 Research ensures every batch undergoes high-performance liquid chromatography (HPLC) and mass spectrometry (MS) to guarantee high purity levels free from trifluoroacetate (TFA) excess or cross-contaminants.

Comparative Analysis: SS-31 vs. Other Mitochondrial Research Compounds

SS-31 belongs to a specialized class of mitochondrial targeting compounds that interact directly with inner mitochondrial membrane lipids. When designing comparative cell culture assays, researchers often compare SS-31 with mitochondrial-derived peptides like MOTS-c and Humanin.

While SS-31 is a small synthetic tetrapeptide optimized for high solubility and rapid cellular uptake, MOTS-c is a larger 16-amino-acid peptide that exhibits different reconstitution kinetics and lower solubility limits in dense aqueous environments. Consequently, MOTS-c frequently requires larger diluent volumes (e.g., 2.5 mL to 3.0 mL per 5 mg vial) to prevent precipitation, whereas SS-31 remains fully soluble even at concentrated levels up to 50 mg/mL. Understanding these structural and solubility differences allows researchers to standardize volumetric concentrations across distinct experimental groups.

Analytical Verification and Quality Assurance at PX1 Research

Precision in peptide research requires uncompromising compound quality. At PX1 Research, all peptides are manufactured in state-of-the-art USA facilities operating under strict GMP-compliant standards. Every lot undergoes rigorous testing in an ISO 17025 accredited laboratory to verify sequence accuracy, mass specificity, and quantitative purity via HPLC and MS.

Furthermore, our compounds undergo comprehensive bacterial endotoxin testing (LAL assay) to guarantee endotoxin levels remain far below established research thresholds (<0.01 EU/mg). This ensures that reconstituted solutions will not induce non-specific inflammatory signaling in delicate cell lines or animal models. Laboratory accounts seeking bulk quantities or custom vial sizing can coordinate orders through our dedicated wholesale lab account portal.

Orders placed Monday through Friday ship same-day directly from our primary distribution centers in California and Arizona, ensuring rapid transit time and minimal environmental exposure for sensitive research materials. For broader technical documentation and experimental protocols, visit the PX1 research library.